Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Jing-Hao ZhangXin ZhangZhen-Hua ZhouXiao-Jun ZhuChao ZhengMan LiShu-Gen JinDe-Wen MaoJing-Dong XueWei-Bing ShiXiao-Ling ChiXian-Bo WangXiao-Dong LiYong LiHui WangQin LiDa-Qiao ZhouCheng-Bao WangChang-He ShiCheng-Zhong LiJian-Hua WuXiao-Ni KongXue-Hua Sun Yue-Qiu Gao

Published in: Evidence-based complementary and alternative medicine : eCAM (2022)

. This trial is registered with ChiCTR-IOR-16009880 on November 16, 2016-retrospectively registered, http://www.chictr.org.cn/showproj.aspx?proj=16836.

Keyphrases

double blind
phase iii
placebo controlled
clinical trial
phase ii
hepatitis b virus
study protocol
open label
cross sectional
combination therapy
preterm birth